Stromacare SAS

StromaCare team was delighted to contribute to The Matrix Biology Europe (MBE) conference, the main European scientific event for the extracellular matrix research community. Our team member, Sophie BACHY presented the role of Bigh3 in the remodeling of the stiffness of cancer stroma. StromaCare is developing a first-in-class antibody targeting BIGH3 for the treatment of solid cancers. https://lnkd.in/edHnBYaJ

To finish our portrait saga, today we present Jose CORREIA . Within StromaCare, he manages quality assurance and quality control of all our programs.

To continue our series of portraits, today Karine Aguera is in the spotlight. She is leading our flagship project STRO-501. She is driving STRO-501 development strategy and manages all regulatory aspects.

Over the next 3 weeks, we invite you to meet StromaCare's key talents through their portraits. This week we introduce you Dr. Ana Hennino. Thanks to her scientific expertise as an immunologist, Ana is well positioned to drive forward the innovative programs that will enable Stromacare SAS to lead the pack in developing cancer tratements targeting the stroma.

Join us at the Health Tech Accelerations Summit organized by BiotechFinances - Medtech - Santé Numérique - DTx - Intelligence Artificielle magazine. In the company of international healthcare players. This meeting will be an opportunity for Stromacare SAS to exchange ideas and collectively reflect on the best strategies for rapidly making therapeutic advances available to patients. https://lnkd.in/eRhA6K-u

Ana Hennino, CSO of Stromacare SAS was invited to participate to #OncoSTARTUPPER 2024 organized by Cancéropôle Lyon Auvergne-Rhône-Alpes and OncoSTART . Ana Hennino shared her experience as Scientic founder of Stromacare SAS . Together with other founders, Ana Hennino participated to a round table witnessing the inspiring genesis of projects in oncology that went from academic to biotech. The event highlighted the local ecosystem of innovation and entrepreneurship in oncology , bringing together experts , researchers and entrepreneurs around the fight cancer. INOVOTION ReACT Therapeutics NH TherAguix MEDICALPS #healthtcare #innovation #cancerologie

Today, we're thrilled to announce that our Stromacare SAS team will be presenting a groundbreaking poster at the #EACR Conference in Rotterdam!🎉 Our poster highlights the latest advancements in of our lead program STRO-501 targeting stromal protein BIGH-3, showcasing how StromaCare is pushing the boundaries of solid cancer treatment. Join us at the poster session (poster number EACR20240447) to learn more about how we're driving change and making a difference. Let's connect and discuss how we can collaborate to further advance this exciting field! Looking forward to seeing you there!   #EACR2024 #StromaCare #Innovation #Research #Biotech #Healthcare #Conference #Rotterdam #Networking #PosterPresentation

Concerned about the environment and its commitment to sustainable development. Stromacare SAS is fully committed to its local partners to protect the environment.   #Dutscher #Clikeco #Elise 

Stromacare SAS is delighted to announce that it will presenting at poster at the European Association for Cancer Research (EACR) in Rotterdam from June 10 to 13. Our scientific team, Karine Aguera , Sandrine Martins, Alexandre Deshiere will be happy to meet you . https://2024.eacr.org

🎉 Exciting News! 🎉 We are thrilled to announce that Stromacare SAS has been awarded the "Best Investment Potential" by OUI Investors, organized by MATWIN. This prestigious recognition highlights the innovative work our team is doing and the impactful potential of our lead program and pipeline.   A huge thank you to MatWin and OUI for this honor, and to our incredible team whose dedication and expertise everyday have made this possible. We are committed to continuing our mission in pioneering a paradigm shift in cancer treatment by targeting the often-overlooked aspect of tumors: THE STROMA.   To all our investors, partners, and supporters - this is just the beginning. Together, we are making a significant impact and driving toward a future where cancer is no longer a life-threatening disease. #HealthcareInnovation #Investment #Award #MatWin #OUI #FutureOfHealthcare #TurenneGroupe #Kreaxi Stéphane Loze To read the full press release, click here: https://bit.ly/4bQf4bW